| Indocyanine green-incorporating nanoparticles for cancer theranostics H Wang, X Li, BWC Tse, H Yang, CA Thorling, Y Liu, M Touraud, ... Theranostics 8 (5), 1227-1242, 2018 | 316 | 2018 |
| BET Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection RJ Mills, SJ Humphrey, PRJ Fortuna, M Lor, SR Foster, GA Quaife-Ryan, ... Cell, 2021 | 175 | 2021 |
| PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer BWC Tse, GJ Cowin, C Soekmadji, L Jovanovic, RS Vasireddy, MT Ling, ... Nanomedicine 10 (3), 375-386, 2015 | 121 | 2015 |
| Paradoxical roles of tumour necrosis factor-alpha in prostate cancer biology BWC Tse, KF Scott, PJ Russell Prostate cancer 2012, 2012 | 98 | 2012 |
| Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality BWC Tse, M Volpert, E Ratther, N Stylianou, M Nouri, K McGowan, ... Oncogene 36 (24), 3417, 2017 | 86 | 2017 |
| Efficient photoacoustic imaging using indocyanine green (ICG) loaded functionalized mesoporous silica nanoparticles Z Chaudhary, GM Khan, MM Abeer, N Pujara, BWC Tse, MA McGuckin, ... Biomaterials Science 7 (12), 5002-5015, 2019 | 76 | 2019 |
| Development of a polymer theranostic for prostate cancer AK Pearce, BE Rolfe, PJ Russell, BWC Tse, AK Whittaker, AV Fuchs, ... Polymer Chemistry 5 (24), 6932-6942, 2014 | 75 | 2014 |
| Antibody-based immunotherapy for ovarian cancer: where are we at? BWC Tse, A Collins, MK Oehler, A Zippelius, VA Heinzelmann-Schwarz Annals of oncology 25 (2), 322-331, 2013 | 68 | 2013 |
| IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms BWC Tse, PJ Russell, M Lochner, I Förster, CA Power PLoS One 6 (9), e24241, 2011 | 59 | 2011 |
| The glycosphingolipid P1 is an ovarian cancer-associated carbohydrate antigen involved in migration F Jacob, M Anugraham, T Pochechueva, BWC Tse, S Alam, R Guertler, ... British journal of cancer 111 (8), 1634, 2014 | 56 | 2014 |
| Evaluation of polymeric nanomedicines targeted to PSMA: effect of ligand on targeting efficiency AV Fuchs, BWC Tse, AK Pearce, MC Yeh, NL Fletcher, SS Huang, ... Biomacromolecules 16 (10), 3235-3247, 2015 | 50 | 2015 |
| Establishing prostate cancer patient derived xenografts: lessons learned from older studies PJ Russell, P Russell, C Rudduck, BWC Tse, ED Williams, D Raghavan The Prostate 75 (6), 628-636, 2015 | 45 | 2015 |
| Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer M Buehler, B Tse, A Leboucq, F Jacob, R Caduff, D Fink, DR Goldstein, ... BioMed research international 2013, 2013 | 41 | 2013 |
| Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease H Rhee, KL Ng, BWC Tse, MC Yeh, PJ Russell, C Nelson, P Thomas, ... Pathology 48 (6), 613-616, 2016 | 35 | 2016 |
| A Spiky Silver‐Iron Oxide Nanoparticle for Highly Efficient Targeted Photothermal Therapy and Multimodal Imaging of Thrombosis KX Vazquez‐Prada, SS Moonshi, Y Wu, F Akther, BWC Tse, ... Small, 2205744, 2023 | 32 | 2023 |
| Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma T Kryza, T Khan, S Puttick, C Li, KA Sokolowski, BWC Tse, T Cuda, ... Theranostics 10 (9), 4116, 2020 | 30 | 2020 |
| From bench to bedside: immunotherapy for prostate cancer BWC Tse, L Jovanovic, CC Nelson, P de Souza, CA Power, PJ Russell BioMed research international 2014, 2014 | 30 | 2014 |
| Ultra-bright green carbon dots with excitation-independent fluorescence for bioimaging A Singh, Z Qu, A Sharma, M Singh, B Tse, K Ostrikov, A Popat, P Sonar, ... Journal of Nanostructure in Chemistry, 1-11, 2022 | 28 | 2022 |
| A high fat diet increases influenza A virus-associated cardiovascular damage JY Siegers, B Novakovic, KD Hulme, R Marshall, CJ Bloxham, ... The Journal of Infectious Diseases, 2020 | 24 | 2020 |
| Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer BS Harrington, Y He, T Khan, S Puttick, PJ Conroy, T Kryza, T Cuda, ... Theranostics 10 (5), 2020 | 22 | 2020 |